Skip to content

13F-HR filed by Commodore Capital LP

Commodore Capital LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 30 holding rows worth $855,509,177.

Accession
0001831942-23-000011
Filed
2023-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, 30 entries on the cover page, a total value of $855,509,177 stated on the cover page (in dollars after the unit check, H1), rows summing to $855,509,177 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MERUS N VN5749R100COM4,428,072$104,413,938dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK5,450,000$74,719,500dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock1,845,000$63,025,200dollars as filed
VAXCYTE INC COM92243G108Stock1,100,000$56,078,000dollars as filed
COGENT BIOSCIENCES INC19240Q201COM5,566,026$54,268,754dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM2,075,000$47,569,375dollars as filed
AMBRX BIOPHARMA, INC. SPONSORED ADR02290A102COM3,518,556$40,463,394dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock2,901,816$39,638,807dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK2,525,753$38,441,961dollars as filed
IMMUNOVANT INC45258J102COM1,000,000$38,390,000dollars as filed
NUVALENT INC COM670703107Stock828,778$38,098,925dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM2,200,000$33,748,000dollars as filed
AKERO THERAPEUTICS INC00973Y108COM565,000$28,577,700dollars as filed
SOLENO THERAPEUTICS INC834203309COM887,500$26,190,125dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock775,000$20,909,500dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW706,665$19,447,421dollars as filed
CELCUITY INC15102K100COM1,694,141$15,484,449dollars as filed
ALPINE IMMUNE SCIENCES INC02083G100COM1,325,000$15,171,250dollars as filed
Adverum Biotechnologies, Inc.00773U108Common Stock10,000,000$15,000,000dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock500,000$14,870,000dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM957,509$13,903,031dollars as filed
KURA ONCOLOGY INC COM50127T109Stock1,400,000$12,768,000dollars as filed
THIRD HARMONIC BIO INC88427A107COM1,700,000$10,863,000dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock739,661$9,075,640dollars as filed
VISTAGEN THERAPEUTICS INC92840H400COM1,575,000$8,253,000dollars as filed
RAYZEBIO INC75525N107COM288,911$6,413,824dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock250,000$5,325,000dollars as filed
Mersana Therapeutics Inc59045L106Common Stock2,244,378$2,850,360dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW116,324$1,424,969dollars as filed
DBV TECHNOLOGIES S A23306J101ADR92,687$126,054dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001831942-23-000011this filing2023-11-14acceptance time not in the bulk data set